Ocumetics Achieves Clinical Milestones; Poised for Value-Defining First-in-Human Lens Implantations

Core Insights - Ocumetics Technology Corp. has successfully completed key clinical milestones and is preparing for first-in-human surgeries of its innovative accommodating intraocular lens [1][2] - The company has made significant clinical progress, including site initiation, ethics committee approval, and patient recruitment for the clinical study in Mexico City [4][6] Financial Activities - Ocumetics has opted not to proceed with the second tranche of a private placement due to the imminent FIH surgeries, having successfully raised $1,124,362 in the first tranche [3] - The company incurred fees of $68,610 and issued 196,029 agent's warrants to Numus Capital Corp. for assistance with the financing [3] Clinical Progress - Key milestones include the completion of clinical study protocol training, receipt of ethics committee approval, and commencement of patient recruitment [4] - The first-in-human implantation of the accommodating intraocular lens is anticipated shortly, with ongoing monitoring of patient progress [4][6] - Planning for Group 2 surgeries is expected to take place in Q1 2026 [4]